670 results on '"Kolb HJ"'
Search Results
2. New concepts about graft-versus-host and graft-versus-leukaemia-reactions. A summary of the 5th International Symposium held in Munich, 21 and 22 March 2002
3. Flow cytometric findings in platelets of patients following allogeneic hematopoietic stem cell transplantation
4. Prognostic significance of increased IL-10 production in patients prior to allogeneic bone marrow transplantation
5. Nutritional status and growth after bone marrow transplantation (BMT) during childhood: EBMT Late-Effects Working Party retrospective data
6. Autocrine regulation of matrix metalloproteinase-9 gene expression and secretion by tumor necrosis factor-α (TNF-α) in NB4 leukemic cells: specific involvement of TNF receptor type 1
7. Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome
8. Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation
9. German consensus on immunogenetic donor search for transplantation of allogeneic bone marrow and peripheral blood stem cells
10. European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching
11. Donor search or autografting in patients with acute leukaemia who lack an HLA-identical sibling? A matched-pair analysis
12. Conversion of AML-blasts to leukemia-derived dendritic cells (DCleu) in ‘DC-culture-media’ shifts the (serum) chemokine-release profile to a more ‘inflammatory’ (in culture) going along with improved antileukemic T-cell-reactivity
13. Clinical relevance of in vitro generated dendritic cells of leukemic origin to predict response to immunotherapy in patients with AML and MDS
14. Session V: Clinical experience with autologous and allogeneic blood stem cell transplantation
15. Session II: Nonmyeloablative stem cell transplantation and adoptive immunotherapy (2)
16. Cerebral angiitis in four patients with chronic GVHD
17. Immunotherapy of recurrent B-cell malignancies after allo-SCT with Bi20 (FBTA05), a trifunctional anti-CD3 × anti-CD20 antibody and donor lymphocyte infusion
18. MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines
19. Ponatinib given for advanced leukemia relapse after allo-SCT
20. Graft-versus-host and graft-versus-leukemia reactions: a summary of the Seventh International Symposium held in Garmisch-Partenkirchen, Germany, February 22nd–25th, 2006, Tolerance and Immunity, an update on lymphoid malignancies
21. Protein C and procollagen III peptide levels in patients with hepatic dysfunction after allogeneic hematopoietic stem cell transplantation
22. An update on graft-versus-host and graft-versus-leukemia reactions: a summary of the sixth International Symposium held in Schloss Ellmau, Germany, January 22–24, 2004
23. Adoption of long-term cultures to evaluate the cryoprotective potential of trehalose for freezing hematopoietic stem cells
24. Busulfan (Bu) Plus Cyclophosphamide (Cy) Versus TBI Plus Cy Conditioning for Allogeneic Stem Cell Transplantation (alloSCT) From Matched Unrelated Donors (MUD) In Adult Patients with AML in First Relapse: A Survey From the Acute Leukemia Working Party of EBMT
25. Graft–versus-Leukemia effect after allogeneic stem cell transplantation and transduced donor leukocyte transfusion
26. Dose-dependent effects of in vivo antithymocyte globulin during conditioning for allogeneic bone marrow transplantation from unrelated donors in patients with chronic phase CML
27. Second Allogeneic Stem Cell Transplantation (allo-SCT) Using Reduced-Intensity Conditioning (RIC) for Acute Myeloid Leukemia (AML) Patients Who Relapsed Following a First RIC Allo-SCT: a Survey From the Acute Leukemia Working Party of EBMT
28. Nonmyeloablative stem cell transplantation in adults with high-risk ALL may be effective in early but not in advanced disease
29. Etiology of acute myeloid leukemia following intensive therapy for AML – relapse, secondary disease or bad luck?
30. New concepts about graft-versus-host and graft-versus-leukaemia-reactions. A summary of the 5th International Symposium held in Munich, 21 and 22 March 2002
31. Flow cytometric findings in platelets of patients following allogeneic hematopoietic stem cell transplantation
32. Histological correlation between different centers using the skin explant model to predict graft-versus-host disease following bone marrow transplantation
33. Leukemic dendritic cells generated in the presence of FLT3 ligand have the capacity to stimulate an autologous leukemia-specific cytotoxic T cell response from patients with acute myeloid leukemia
34. Graft-versus-leukaemia with little graft-versus-host disease? A clinical phase I/II study using transfusion of transduced donor T-cells for donor leukocyte transfusion
35. Large vessel vasculitis: manifestation of graft-versus-host disease?
36. Malignant Neoplasms in Long-Term Survivors of Bone Marrow Transplantation
37. Nutritional status and growth after bone marrow transplantation (BMT) during childhood: EBMT Late-Effects Working Party retrospective data
38. Human parvovirus B19-associated disease in bone marrow transplantation
39. The Relevance of Plasminogen Activator Inhibitor 1 (PAI-1) as a Marker for the Diagnosis of Hepatic Veno-Occlusive Disease in Patients after Bone Marrow Transplantation
40. Mechanisms of graft-versus-leukemia effects after allogeneic stem cell transplantation: effects on the leukemia stem cell?
41. German consensus on immunogenetic donor search for transplantation of allogeneic bone marrow and peripheral blood stem cells
42. Endothelial cell markers in bone marrow transplant recipients with and without acute graft-versus-host disease
43. Donor search or autografting in patients with acute leukaemia who lack an HLA-identical sibling? A matched-pair analysis
44. Chronic myeloid leukemia associated hypereosinophilic syndrome with a clonal t(4;7)(q11;q32)
45. Idarubicin monotherapy in multiply pretreated leukemia patients: response in relation to P-glycoprotein expression
46. ADOPTIVE IMMUNOTHERAPY IN CANINE CHIMERAS1
47. The fate of gene modified T-cells can be followed in 2 patients without immunosuppression after allogeneic stem cell transplantation
48. Function of HSV-TK suicide gene transduced canine lymphocytes
49. Modulation of acute graft-versus-host-disease after allogeneic bone marrow transplantation by tumor necrosis factor alpha (TNF alpha) release in the course of pretransplant conditioning: role of conditioning regimens and prophylactic application of a monoclonal antibody neutralizing human TNF alpha (MAK 195F)
50. Function of HSV-TK suicide gene transduced canine cytotoxic T lymphocytes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.